About this author

Malgorzata Kluba, PhD

Senior Biotechnology Analyst

Malgorzata Kluba has been a Senior Biotechnology Analyst at Candriam since 2019.

Before joining Candriam Malgorzata spent four years as an R&D scientist at ActoBio Therapeutics (Intrexon Actobiotics) in Belgium – a synthetic biology company where she had been working on novel drug delivery platform. She has also worked as a journalist for a life sciences communication agency (BioVox / Tunstone Communications), focusing on Belgian biotechnology market.

Malgorzata holds PhD degree in biochemistry and biotechnology from University of Leuven, Belgium, where she researched cancer signalling pathways.

Discover the latest articles by Malgorzata Kluba, PhD

Malgorzata Kluba, Rudi Van den Eynde, Oncology, Equities

World Cancer Day 2023

And we would rather not have to go through this – which would mean we won the battle and cancer is curable.

Find it fast

Get information faster with a single click

Get insights straight to your inbox